Open-Label Study of the Safety and Immunogenicity of HEPLISAV™ Hepatitis B Virus Vaccine
Clinical trial NCT00511095 · COMPLETED
Trial details
- NCT number
- NCT00511095
- Sponsor
- Dynavax Technologies Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2007-10-01
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.